Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
Martín Ruiz OrtizJavier MuñizMaría Asunción Esteve-PastorFrancisco MarínInmaculada RoldánAngel CequierManuel Martínez-SellésHugo González SaldivarVicente BertomeuManuel AnguitaPublished in: Journal of cardiovascular pharmacology and therapeutics (2020)
In this "real-world" registry, the differences in major events rates in octogenarians with AF were not statistically significant in those treated with DOACs versus VKAs.
Keyphrases
- atrial fibrillation
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- direct oral anticoagulants
- heart failure
- prognostic factors
- left atrial
- physical activity
- cross sectional
- patient reported outcomes
- oral anticoagulants
- left atrial appendage
- acute coronary syndrome
- venous thromboembolism
- middle aged
- patient reported
- mitral valve